Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Lewis B, Kinter"'
Autor:
David A. Brott, Håkan A.S. Andersson, Jane Stewart, Lorna Ewart, Greg Christoph, Johannes Harleman, Duncan Armstrong, Lewis B. Kinter
Publikováno v:
Toxicology Reports, Vol 1, Iss C, Pp 1202-1212 (2014)
Background: Ticagrelor is an orally available, direct acting and reversible P2Y12 receptor antagonist approved for treatment of acute coronary syndrome. The objectives of these studies were to (1) evaluate the Ticagrelor 2-year rat carcinogenicity bi
Externí odkaz:
https://doaj.org/article/a64f0305449b4cd8bd310ba984abd2e4
Autor:
Lewis B, Kinter, David K, Johnson, Robert H, Weichbrod, Ernest D, Prentice, Richard C, Simmonds, Paul W, Houghton, Robert A, Whitney, Joseph, DeGeorge, W Ron, DeHaven, Klaas, Kramer, Louis, DeTolla
Publikováno v:
ILAR J
The organization and function of the institutional animal care and use committee (IACUC) is the key component of government regulation and oversight of necessary scientific research using live animals and of AAALAC - International accreditation of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baec0be759c8e90ada535d51a69fb1a5
https://doi.org/10.1093/ilar/ilac006
https://doi.org/10.1093/ilar/ilac006
Publikováno v:
ILAR journal. 62(3)
The Institute for Laboratory Animal Research (ILAR) was created within the National Academies of Sciences, Engineering, and Medicine (National Academies) in 1953 when biomedical research using animals was in its infancy in terms of quantity, quality,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f15846d13151b1ea2316ff4aad347854
https://pubmed.ncbi.nlm.nih.gov/36515581
https://pubmed.ncbi.nlm.nih.gov/36515581
Publikováno v:
Toxicology and Applied Pharmacology. 336:66-74
Multiplex biomarker panel assays would enable early de-risking of discovery compound related kidney safety liabilities. The objective of this study was to evaluate the usefulness of the Myriad RBM Human KidneyMAP (Multi-Analyte Profile)® v.1.0 panel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f7d5d75e6edbc3e2a4d8a6aaa52927f
https://doi.org/10.1016/j.taap.2017.10.010
https://doi.org/10.1016/j.taap.2017.10.010
Publikováno v:
ILAR journal. 62(1-2)
Animals have been closely observed by humans for at least 17 000 years to gain critical knowledge for human and later animal survival. Routine scientific observations of animals as human surrogates began in the late 19th century driven by increases i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64641d908c316d1c923b7e1f2068747e
https://pubmed.ncbi.nlm.nih.gov/34181728
https://pubmed.ncbi.nlm.nih.gov/34181728
Autor:
Joseph J. DeGeorge, Lewis B. Kinter
Publikováno v:
ILAR Journal. 57:101-108
Human discovery of pharmacologically active substances is arguably the oldest of the biomedical sciences with origins >3500 years ago. Since ancient times, four major transformations have dramatically impacted pharmaceutical development, each driven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecf2c740d6d4aad550a1ed0a4246f1e0
https://doi.org/10.1093/ilar/ilw027
https://doi.org/10.1093/ilar/ilw027
Publikováno v:
Environmental Health Perspectives
Background Employers, courts, and the general public judge the credibility of professionals based on credentials such as academic degrees, publications, memberships in professional organizations, board certifications, and professional registrations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a3953841f80c73578773209191987e
https://doi.org/10.1289/ehp.1408643
https://doi.org/10.1289/ehp.1408643
Autor:
Duncan Armstrong, David Brott, Lewis B. Kinter, Johannes Harleman, Håkan H. A. S. Andersson, Lorna Ewart, Jane Stewart, Greg Christoph
Publikováno v:
Toxicology Reports, Vol 1, Iss C, Pp 1202-1212 (2014)
Background Ticagrelor is an orally available, direct acting and reversible P2Y 12 receptor antagonist approved for treatment of acute coronary syndrome. The objectives of these studies were to (1) evaluate the Ticagrelor 2-year rat carcinogenicity bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::782ef1db606ddeed7cb148cdf5f3457a
https://doi.org/10.1016/j.toxrep.2014.11.010
https://doi.org/10.1016/j.toxrep.2014.11.010
Autor:
Lewis B. Kinter, David K Johnson
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 99:106595
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ddd95a6c4ef6921c40c2d90cd7d92e3
https://doi.org/10.1016/j.vascn.2019.05.156
https://doi.org/10.1016/j.vascn.2019.05.156
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 99:106595
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca5e59db4ca366fd2c8b9debeb0494bb
https://doi.org/10.1016/j.vascn.2019.05.155
https://doi.org/10.1016/j.vascn.2019.05.155